| Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... EBioMedicine 83, 2022 | 35 | 2022 |
| Molecular level characterization of circulating aquaporin-4 antibodies in neuromyelitis optica spectrum disorder J Li, SA Bazzi, F Schmitz, H Tanno, JR McDaniel, CH Lee, C Joshi, ... Neurology: Neuroimmunology & Neuroinflammation 8 (5), e1034, 2021 | 17 | 2021 |
| Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier K Kisler, AP Sagare, D Lazic, S Bazzi, E Lawson, CJ Hsu, Y Wang, ... Molecular Neurodegeneration 18 (1), 7, 2023 | 8 | 2023 |
| Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy SA Bazzi, C Maguire, N Holay, J Geltman, K Hurley, C DiPasquale, ... Multiple Sclerosis and Related Disorders 68, 104195, 2022 | 1 | 2022 |
| SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics N Siles, M Schuler, C Maguire, D Amengor, A Nguyen, R Wilen, J Rogers, ... medRxiv, 2023 | | 2023 |
| Alcohol Shifts T Cell Phenotypes and EAE Clinical Severity in a Sex-Specific Manner S Bazzi, C Maguire, K Motovilov, J Rogers, E Melamed MULTIPLE SCLEROSIS JOURNAL 29, 824-824, 2023 | | 2023 |
| Alcohol induces concentration-dependent transcriptomic changes in oligodendrocytes SA Bazzi, C Maguire, RD Mayfield, E Melamed bioRxiv, 2023 | | 2023 |
| Correction: Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier K Kisler, AP Sagare, D Lazic, S Bazzi, E Lawson, CJ Hsu, Y Wang, ... Molecular Neurodegeneration 18 (1), 14-14, 2023 | | 2023 |
| Longitudinal COVID-19 immune trajectories in autoimmune patients on anti-CD20 therapy S Bazzi, C Maguire, N Holay, J Geltman, K Hurley, L Ehrlich, T Triplett, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 230-230, 2022 | | 2022 |
| Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study (preprint) A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... | | 2022 |
| A new software and analysis suite for experimental autoimmune encephalomyelitis C Maguire, B Caslin, S Bazzi, E Melamed, D Wylie MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 118-118, 2020 | | 2020 |
| Binge alcohol consumption in murine models of multiple sclerosis leads to sex-specific disease development S Bazzi, B Caslin, M Raskin, A Karmakar, K Mohler, C Maguire, ... MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 645-645, 2020 | | 2020 |
| P1‐034: UPREGULATION OF ENDOTHELIAL PICALM EXPRESSION USING AN FDA‐APPROVED DRUG REDUCES AMYLOID‐β LOAD IN THE MURINE BRAIN K Kisler, AP Sagare, S Bazzi, D Lazic, CJ Hsu, EJ Lawson, AR Nelson, ... Alzheimer's & Dementia 15, P245-P246, 2019 | | 2019 |
| COVID-19 and Neurological Symptoms S Bazzi | | |
| Debate on the Significance of Neurological Symptoms of COVID-19 S Bazzi | | |
